Hemo Organic Limited will seek shareholder approval to raise funds in one or more tranches through the issue of equity shares and/or convertible securities, including convertible warrants, via methods such as preferential allotment, private placement, or public issue, according to a regulatory filing with the BSE Limited on September 19, 2026. The company’s trading window will be closed from the end of business hours on September 19, 2026, until 48 hours after the conclusion of the board meeting scheduled for September 23, 2026.
FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com
BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737
ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)
© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.
Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)
